Pleasanton, CA, United States of America

Mark Lortz

This inventor holds 14 USPTO granted patents and 9 published patent applications, primarily in Health Monitoring Systems. Top assignees: Abbott Diabetes Care Inc., Therasense, Inc.. Active years: 2006-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mark Lortz. Retrieved from https://idiyas.com/inventor/mark-lortz

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 14 

% Patents Active = 35.7

Average Co-Inventor Count = 7.0

ph-index = 10

Forward Citations = 1,289(Granted Patents)


Location History:

  • San Francisco, CA (US) (2012 - 2014)
  • Pleasanton, CA (US) (2006 - 2016)

Company Filing History:


Years Active: 2006-2016

Loading Chart...
Areas of Expertise:
Blood Glucose Tracking
Patient Health Management
Mobile Health Solutions
PDA Based Systems
Central Server Systems
Data Graphing
Health Condition Management
Mobile Device Treatment
14 patents (USPTO):Explore Patents

Title: Mark Lortz: Innovator in Blood Glucose Tracking Technology

Introduction

Mark Lortz is a notable inventor based in Pleasanton, California, with a significant contribution to the field of medical technology. He holds 14 patents, primarily focused on blood glucose tracking apparatus and methods. His innovations have played a crucial role in improving diabetes management for patients.

Latest Patents

Among his latest patents is a blood glucose tracking apparatus that features a measurement module for glucose testing. This apparatus includes a housing with a test strip receptacle and a connector portion designed for mechanical removable attachment to a hand-held computer. The electronics within the device determine the glucose levels present in a sample of body fluid when the test strip is positioned correctly. The results are then communicated to the hand-held computer via the connector portion, enhancing the ease of monitoring glucose levels.

Career Highlights

Mark Lortz has worked with prominent companies in the medical technology sector, including Abbott Diabetes Care Inc. and Therasense, Inc. His experience in these organizations has contributed to his expertise in developing innovative solutions for glucose monitoring.

Collaborations

Throughout his career, Mark has collaborated with notable professionals in the field, including Steven H. Drucker and Charles T. Liamos. These collaborations have further enriched his work and led to advancements in glucose tracking technology.

Conclusion

Mark Lortz's contributions to blood glucose tracking technology have made a significant impact on diabetes management. His innovative patents and collaborations reflect his dedication to improving healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…